📰 Antitrust Division News
Page 39 - Antitrust Division News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Antitrust Division. Real-time updates on events, politics, business and more.
August 22, 2023
WASHINGTON, Aug 22, 2023 (BSS/AFP) - The Israel-based drugmaker Teva Pharmaceuticals has agreed to pay a $225 million fine to
August 22, 2023
Glenmark Pharmaceuticals has entered into an agreement with the DOJ to resolve all of its court proceedings involving historical pricing practices by former employees relating to the generic drug pravastatin between 2013 and 2015.
August 22, 2023
If the company adheres to the terms of the agreement, including the payment of USD 30 million, payable in six installments, the DOJ will dismiss the pending Superseding Indictment, it added.
August 22, 2023
Israel-based generic drugs multinational blames single former employee for striking agreements with competitors that limited competition between 2013-2015
August 22, 2023
US-based Glenmark Pharmaceuticals Inc, a subsidiary of the company, has entered into a three-year deferred prosecution agreement with DOJ involving historical pricing practices by former employees relating to the generic drug pravastatin between 2013 and 2015
August 22, 2023
The US has fined top drug-making companies Teva Pharmaceuticals and Glenmark Pharmaceuticals a total of $255 million for price-fixing fixing medications, including a generic cholesterol drug that they will now divest.The Department of Justice ...
August 22, 2023
Generic drug maker Teva Pharmaceutical Industries (NASDAQ:TEVA) is to pay US$225 million in fines after admitting price-fixing on a range of drugs in the...
August 22, 2023
For the first time in 40 years, the Federal Trade Commission (FTC) has taken action to enforce Section 8 of the Clayton Act, which prohibits so-called interlocking directorates. In the...
August 22, 2023
Two major generic drug companies Monday settled charges of criminal price fixing with the Department of Justice (DOJ). The U.S. division of Israel-based Teva will pay a $225 million criminal penalty over five years, and the U.S. division of India-based Glenmark will pay a $30 million criminal penalty, the DOJ announced. The two companies entered…
August 22, 2023
With the promise of additional 5G functionality for consumer vehicles comes a concomitant focus in the IP world on having a workable 5G patent licensing regime for automakers.